The FINANCIAL — The Asian Development Bank (ADB) has allocated $20.3 million in technical assistance to help its developing members access vaccines for the coronavirus disease (COVID-19) and establish systems to enable equitable and efficient vaccine distribution. The funds will be available for ADB developing members to support vaccine-related
More
The FINANCIAL — Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that the independent, NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273, its
More
The FINANCIAL — Global pharmaceutical company Janssen will begin clinical trials of its potential vaccine in the UK from today (Monday 16 November), involving 6,000 volunteers across the country. The Janssen Pharmaceutical Companies, part of Johnson & Johnson, is the latest study
More
The FINANCIAL — Medicago, a biopharmaceutical company headquartered in Quebec City, and GSK are pleased to announce the start of Phase 2/3 clinical trials of its plant-derived vaccine candidate for COVID-19 to evaluate its efficacy, safety, and immunogenicity. Based on the positive
More
The FINANCIAL — After a vaccine presenting as 90% effective in stage three clinical trials was announced by Pfizer on Monday, 76% of Britons and 66% of Americans say they would be happy to be vaccinated against COVID-19. This likelihood to be
More
The FINANCIAL — On the occasion of the World Health Assembly, the world’s research-based and generic & biosimilar pharmaceutical industry bodies delivered a statement declaring their shared commitment to equitable access to COVID-19 medicines and vaccines. In their joint statement, the two global pharmaceutical industry
More
The FINANCIAL — Pfizer Inc. and BioNTech SE (Nasdaq: BNTX) today announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted
More
The FINANCIAL — Takeda Pharmaceutical Company Limited announced that it will import and distribute 50 million doses of Moderna’s COVID-19 vaccine candidate, mRNA-1273, starting in the first half of 2021, pending licensure in Japan. This effort is part of a three-way agreement
More
The FINANCIAL — Since 2008, Philip Morris Investments B.V. (PMIBV), a subsidiary of Philip Morris International (PMI) (NYSE: PM), has been a shareholder of Medicago (in which it currently holds an approximately one-third equity stake) and has supported Medicago’s innovative plant-derived research and development focused
More
The FINANCIAL — The World Bank’s Board of Executive Directors approved an envelope of $12 billion for developing countries to finance the purchase and distribution of COVID-19 vaccines, tests, and treatments for their citizens. The financing, which aims to support vaccination of
More